No MO or IMH (n = 17) | MO only (n = 8) | MO and IMH (n = 14) | p value | |
---|---|---|---|---|
Age, years | 58 ± 10 | 55 ± 9 | 59 ± 8 | 0.70 |
Male | 16 (94%) | 8 (100%) | 10 (71%) | 0.12 |
Current smoker | 9 (53%) | 4 (50%) | 7 (50%) | 1.00 |
Hypertension | 7 (41%) | 3 (38%) | 1 (7%) | 0.08 |
Hypercholesterolemia | 11 (65%) | 3 (38%) | 8 (57%) | 0.50 |
Family history of premature heart disease | 6 (35%) | 3 (38%) | 6 (43%) | 0.91 |
Diabetes mellitus | 0 (0%) | 1 (13%) | 1 (7%) | 0.31 |
Pain to balloon time, min (median (IQR*)) | 205 (126) | 194 (77) | 210 (200) | 0.93 |
Infarct territory | ||||
Anterior | 5 | 4 | 6 | 0.69 |
Inferior | 11 | 3 | 6 | |
Lateral | 1 | 1 | 1 | |
GP†IIb/ÍIIa inhibitor used | 3 (18%) | 3 (38%) | 4 (29%) | 0.64 |
TIMI flow pre-PCI ≥ 2 | 4 (24%) | 0 (0%) | 1 (7%) | 0.25 |
TIMI flow post PCI | ||||
Grade 2 | 1 (6%) | 1 (11%) | 0 (0%) | 0.69 |
Grade 3 | 16 (94%) | 8 (89%) | 14 (100%) | |
Peak CK‡ (U/l) | 1234 ± 976 | 1711 ± 1442 | 2640 ± 1997 | 0.051 |